Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

detailed view of different pathogens

Quick and Accurate Detection of Pathogens

MP3 WAV

  • Infections of the central nervous system or CNS are often serious and sometimes deadly and yet, determining which pathogen is causing the infection remains challenging. To find whether a virus or bacteria is the cause of someone’s brain inflammation, doctors need a tissue sample, grow it in the lab, and then test it to identify it. Often the tests involve using antibodies of known pathogens.  

    We have technology that gets around having to grow the sample, but it also only works if we have a good guess of what’s causing the infection. It’s like trying to identify a criminal only if you already know who they are! 

    Today, we know the cause of just half of all CNS infections, making them tough to treat. However, scientists have developed a test called mNGS or metagenomic next-generation sequencing.  

    Using cerebrospinal fluid, the test can simultaneously detect a range of microorganisms, including bacteria, viruses, fungi, and parasites in just hours. Researchers took 7 years to develop the test and then checked its effectiveness on nearly 5,000 samples. Among the hundreds of positive samples, nearly 800 organisms were identified. Because it scans all genetic material, it can detect rare pathogens, making it valuable for diagnosing mystery infections. The downside is that at $3,000, only patients in rich countries can afford the test for now.  

More Information

Metagenomics Next Generation Sequencing (mNGS): An Exciting Tool for Early and Accurate Diagnostic of Fungal Pathogens in Plants
In this review, we focus on how mNGS technology, including metabarcoding, is applied for detecting fungal pathogens and its promising developments for the future.

Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections
Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) is an agnostic method for broad-based diagnosis of central nervous system (CNS) infections. 

The Real-World Clinical Impact of Plasma mNGS Testing: an Observational Study
Plasma metagenomic next-generation sequencing (mNGS) testing is a promising diagnostic modality for infectious diseases, but its real-world clinical impact is poorly understood. We reviewed patients who had undergone plasma mNGS at a general hospital to evaluate the clinical utility of plasma mNGS testing.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.